Andrew W Chung

1PUBLICATIONS
16CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Andrew W Chung, Kartik Anand, Ann C Anselme

Pageof 1

Frequent Collaborators

1 joint publications

Kartik Anand

1 joint publications

Ann C Anselme

1 joint publications

Nakul Gupta

1 joint publications

Luz A Venta

1 joint publications

Mary R Schwartz

1 joint publications

Yitian Xu

1 joint publications

Licheng Zhang

1 joint publications

Angel A Rodriguez

1 joint publications

Jorge Darcourt

1 joint publications

Joe Ensor

Frequent Collaborators

1 joint publications

Kartik Anand

1 joint publications

Ann C Anselme

1 joint publications

Nakul Gupta

1 joint publications

Luz A Venta

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on : Jul 20, 2019

6.1K
See more related videos

Top Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on : Jul 20, 2019

6.1K
See more related videos